Şaban Keleşoğlu
Impact in
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
- Heart Rate Variability and Autonomic Control
- Cardiovascular Health and Disease Prevention
Papers in
-
- Cardiovascular Disease and Adiposity 6
- Acute Myocardial Infarction Research 6
- Atrial Fibrillation Management and Outcomes 5
- Oncology 12
- Inflammatory Biomarkers in Disease Prognosis 12
- Co-authors
- Yücel Yılmaz (22 shared papers)Deniz Elçik (24 shared papers)Nihat Kalay (15 shared papers)Abdurrahman Oğuzhan (7 shared papers)Mehmet Güngör Kaya (9 shared papers)Mahmut Akpek (6 shared papers)İdris Ardıç (7 shared papers)Mikail Yarlıoğlueş (5 shared papers)
In The Last Decade
Şaban Keleşoğlu
38 papers receiving 391 citations
Peers
Comparison fields: 5 of 47
- Internal Medicine 31
- Cardiology and Cardiovascular Medicine 136
- Nephrology 41
- Oncology 129
- Immunology 27
Countries citing papers authored by Şaban Keleşoğlu
This map shows the geographic impact of Şaban Keleşoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Şaban Keleşoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Şaban Keleşoğlu more than expected).
Fields of papers citing papers by Şaban Keleşoğlu
This network shows the impact of papers produced by Şaban Keleşoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Şaban Keleşoğlu. The network helps show where Şaban Keleşoğlu may publish in the future.
Co-authors
The 25 scholars most cited alongside Şaban Keleşoğlu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 45 | |
| 2 | 2021 | 38 | |
| 3 | 2021 | 27 | |
| 4 | 2024 | 25 | |
| 5 | 2011 | 24 | |
| 6 | 2021 | 23 | |
| 7 | 2010 | 21 | |
| 8 | 2011 | 20 | |
| 9 | 2022 | 17 | |
| 10 | 2011 | 17 | |
| 11 | 2022 | 16 | |
| 12 | 2022 | 13 | |
| 13 | 2023 | 12 | |
| 14 | 2014 | 11 | |
| 15 | 2023 | 11 | |
| 16 | 2014 | 10 | |
| 17 | 2024 | 8 | |
| 18 | 2021 | 8 | |
| 19 | 2024 | 7 | |
| 20 | 2021 | 7 |
About Şaban Keleşoğlu
Şaban Keleşoğlu is a scholar working on Cardiology and Cardiovascular Medicine, Oncology, Nephrology, Surgery and Radiology, Nuclear Medicine and Imaging, having authored 45 papers that have together received 399 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (12 papers), Cardiovascular Disease and Adiposity (6 papers), Acute Myocardial Infarction Research (6 papers), Atrial Fibrillation Management and Outcomes (5 papers), Acute Kidney Injury Research (5 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Chronic Kidney Disease and Diabetes (3 papers) and Cardiac Imaging and Diagnostics (3 papers). The work is most often cited by research in Internal Medicine (31 citations), Cardiology and Cardiovascular Medicine (136 citations), Nephrology (41 citations), Oncology (129 citations) and Immunology (27 citations). Şaban Keleşoğlu has collaborated with scholars based in Türkiye, Cambodia and Somalia. Frequent co-authors include Yücel Yılmaz, Deniz Elçik, Nihat Kalay, Abdurrahman Oğuzhan, Mehmet Güngör Kaya, Mahmut Akpek, İdris Ardıç, Mikail Yarlıoğlueş, Mehmet Tuğrul İnanç and Orhan Doğdu. Their work appears in journals such as Journal of Clinical Medicine, Biomarkers in Medicine, Journal of Investigative Medicine, The Journal of Rheumatology and Perfusion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.